semaglutide supply issues Compounded' weight-loss drugs are a growing problem for state regulators • Utah News Dispatch Novo Nordisk expects Ozempic supply

Semaglutide, originally developed for type 2 diabetes, has weight loss benefits and concerns about long-term use and potential weight regain

Shiner Law Group, for instance, provides comprehensive information on potential attorneys heading your case

These include: Nausea (affecting 2040% of patients initially) Vomiting and diarrhoea Constipation Abdominal discomfort or bloating Reduced appetite These symptoms are usually mild to moderate and tend to diminish over several weeks as the body adjusts to the medication

Temporary nausea, constipation, or mild digestive issues are common early on but usually improve with time